15-65050041-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_178859.4(SLC51B):āc.37G>Cā(p.Gly13Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000902 in 1,551,568 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178859.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC51B | NM_178859.4 | c.37G>C | p.Gly13Arg | missense_variant | 2/4 | ENST00000334287.3 | NP_849190.2 | |
SLC51B | XM_005254159.6 | c.37G>C | p.Gly13Arg | missense_variant | 2/4 | XP_005254216.1 | ||
RASL12 | XM_017022296.2 | c.*1949C>G | 3_prime_UTR_variant | 5/5 | XP_016877785.1 | |||
RASL12 | XM_005254434.5 | c.426-4297C>G | intron_variant | XP_005254491.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC51B | ENST00000334287.3 | c.37G>C | p.Gly13Arg | missense_variant | 2/4 | 2 | NM_178859.4 | ENSP00000335292.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000320 AC: 5AN: 156348Hom.: 0 AF XY: 0.0000243 AC XY: 2AN XY: 82254
GnomAD4 exome AF: 0.00000786 AC: 11AN: 1399360Hom.: 0 Cov.: 30 AF XY: 0.00000580 AC XY: 4AN XY: 690222
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74362
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with SLC51B-related conditions. This variant is present in population databases (rs745589743, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 13 of the SLC51B protein (p.Gly13Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at